How will CGT changes impact startups? | ABC NEWS

4DMedical has become one of the most closely watched healthcare companies on the ASX this year, as investors and hospitals alike pay attention to an Australian technology company that is changing how lung function is analysed.

With a background in mechanical engineering, CEO Andreas Fouras took technology originally developed to study airflow in wind tunnels and adapted it to measure airflow and blood flow inside the human body. Two decades later, 4DMedical is selling into some of America’s biggest hospitals, but back home, there’s a lot of debate around how the new CGT rules will impact Australian startups like this one.

Alan Kohler speaks to Andreas Fouras on That's Business.

Subscribe: http://ab.co/1svxLVE

Note: In most cases, our captions are auto-generated.

#ABCNEWS #ABCNEWSAustralia